{
    "clinical_study": {
        "@rank": "6505", 
        "acronym": "RASHEC", 
        "arm_group": [
            {
                "arm_group_label": "Robotic surgery", 
                "arm_group_type": "Experimental", 
                "description": "Experimental method, to be compared with standard care"
            }, 
            {
                "arm_group_label": "Abdominal surgery", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is intended to explore differences in oncologic and surgical safety between\n      robotic assisted laparoscopy and conventional abdominal surgery for high risk endometrial\n      cancer."
        }, 
        "brief_title": "Robotic Versus Abdominal Surgery for Endometrial Cancer", 
        "completion_date": {
            "#text": "April 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Endometrial Neoplasms", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Endometrial Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Hypothesis: Robotic assisted laparoscopy (RAL)is equal in terms of oncologic and surgical\n      safety as conventional abdominal surgery (AS) for high risk endometrial cancer (EC).\n\n      Methods: Women with high risk EC (defined as high grade endometrial, clear cell or serous)\n      are randomized to either RAL or AS. Both groups will undergo complete surgical staging\n      (hysterectomy, bilateral salpingoophorectomy, pelvic and paraaortal lymphadenectomy)\n\n      Primary endpoint: Number of harvested lymph nodes per station Secondary endpoints:\n      Recurrences up to 3 year after surgery. Lymphatic side-effects, quality of life, cost,\n      surgical morbidity."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18-75 years of age\n\n          -  High risk endometrial cancer\n\n        Exclusion Criteria:\n\n          -  WHO performance>1\n\n          -  Severe comorbidity, ASA>3\n\n          -  Unable to understand information"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01847703", 
            "org_study_id": "2013/361-31/1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Robotic surgery", 
                "intervention_name": "Robotic surgery", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Abdominal surgery", 
                "description": "Current gold standard", 
                "intervention_name": "Abdominal surgery", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2013", 
        "location": {
            "contact": {
                "email": "henrik.falconer@karolinska.se", 
                "last_name": "Henrik Falconer, MD, PhD", 
                "phone": "+46707742146"
            }, 
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden", 
                    "zip": "17176"
                }, 
                "name": "Karolinska University Hospital"
            }, 
            "investigator": {
                "last_name": "Henrik Falconer, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Trial Comparing Robotic and Abdominal Surgery for High Risk Endometrial Cancer", 
        "overall_official": {
            "affiliation": "Karolinska Institutet", 
            "last_name": "Henrik Falconer, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Extracted lymphatic tissue from 3 stations (above inferior mesenteric artery, below inferior mesenteric artery, pelvic) is analysed by a pathologist and the number of nodes for each station recorded and compared between the two groups", 
            "measure": "Number of harvested lymph nodes", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01847703"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karolinska Institutet", 
            "investigator_full_name": "Henrik Falconer", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Cancer recurrences will be recorded up to 3 years after surgery and categorized according to anatomical site", 
                "measure": "Recurrence of cancer", 
                "safety_issue": "Yes", 
                "time_frame": "3 years"
            }, 
            {
                "description": "Lymphatic side-effects will be monitored by repeated computed tomography (CT) 3 months and 12 months after surgery. Enrolled women will be asked specific, validated questions at follow-up", 
                "measure": "Lymphatic side-effects", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "All included participants will be asked to fill out a questionnaire (EORTC) to assess quality of life before and 1 year after surgery", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "All costs related to each procedure including complications, re-admissions, rehabilitation, medication, radiology will be compared after 1 year.", 
                "measure": "Healthcare cost", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Karolinska Institutet", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Karolinska Institutet", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}